Snoasis Medical
Golden
About Snoasis Medical
Snoasis Medical develops and commercializes regenerative tissue and medical device products for dental surgery. The company's lead product, BioXclude de-epithelialized amnion-chorion allograft, processed using Purion, delivers multiple extra-cellular matrix proteins, growth factors, and cytokines to provide a barrier membrane that enhances healing. The Purion also processed allografts are easy to use and can be stored for up to five years at ambient conditions.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $250.0K
- Funding stage: M&A
- Last round: Grant (Nov 2021)
- Website: snoasismedical.com
- Phone: 866-521-8247
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/snoasis-medical-167364 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.